Meet the Professor sessions
Are you interested in active debate and discussion with distinguished professors at the ISN Frontiers Meeting 2018?
Meet the Professor sessions will be held on Friday, February 23 and Saturday, February 24, 2018 between 8 and 9 AM. It is a unique chance for you to talk about your topics of interest within a close-knit group of distinguished professors. Topics are not limited to your own research, but can also be published articles (review or original articles) in recent journals.
Moderators listed below are going to help you to prepare your presentation and brief you before each session. Exceptionally, only paper handouts can be used during this session.
- Pre-registration is necessary for application (inquiry No. is needed).
- Participants registered name, affiliation, and e-mail address.
- Participants can select one professor per day.
Meet the Professor sessions (six participants per session)
Venue: Keio Plaza Hotel Tokyo, Main Tower 5F Concord Ballroom A
Friday February 23, 2018, 8.00-9.00 a.m.
Ziad A. Massy, M.D., Ph.D. is Professor of Nephrology and Head of the Division of Nephrology at the Paris West University (UVSQ)- Ambroise Paré University Hopsital, Paris, and Co-Director of Research Unit INSERM U-1018 team 5 at the UVSQ, Versailles/Villejuif, France. His research areas of special interest include cardiovascular disease, vascular calcification, hyperlipidemia, uremic toxins, oxidative stress, and chronic renal failure. He has published multiple original articles and reviews, and has served on the editorial boards of nephrology journals such as Kidney International and Nephrology Dialysis Transplantation. He is also a member of ERA-EDTA Council, chair for the ERA-EDTA Registry, core-member of the Executive KDIGO board, the EURECAM Working Group Advisory Board, core-member of the CKD-MBD WG Working Group Advisory Board, and a current member and former co-chairman of European Uremic Toxins (EUTox) group. We welcome young participants hoping to discuss with Prof. Massy. We also welcome researchers who want to present their preliminary data in this session. The moderators will make the utmost effort to meet the needs of participants.The Paris Ouest University, France
Hirotaka Komaba (Tokai University, Japan)
Isao Matsui (Osaka University, Japan)
Topic: CKD-MBD and cardiovascular disease
Tamara Isakova, MD, MMSc is Associate Professor of Medicine in the Division of Nephrology and Hypertension at the Northwestern University Feinberg School of Medicine and Director of the Center for Translational Metabolism and Health within the Institute for Public Health and Medicine. Dr. Isakova is a graduate of the State University of New York Downstate College of Medicine, and she completed internal medicine training at the Massachusetts General Hospital and nephrology training at the combined Massachusetts General Hospital and Brigham & Women’s Hospital nephrology fellowship program. Dr. Isakova conducts clinical research in the area of disordered mineral metabolism in chronic kidney disease. She has received research support from the American Kidney Fund, the American Heart Association, the American Society of Nephrology, and the National Institute of Health. Dr. Isakova provides clinical care for patients with chronic kidney disease, bone and mineral metabolism disorders, and kidney stones. We welcome young participants hoping to discuss with Prof. Tamara Isakova.Northwestern University Feinberg School of Medicine, USA
Tadashi Sofue (Kagawa University, Japan)
Rieko Eriguchi (Kaizuka Hospital, Japan)
Topic: Rationale and approaches to phosphate and FGF23 reduction in patients with chronic kidney disease
Mark Cooper is the inaugural Head of the Department of Diabetes, Central Clinical School, Monash University. He was previously the Chief Scientific Officer of the Baker IDI Heart and Diabetes Institute as well as the Director of the Juvenile Diabetes Research Foundation Centre (JDRF) for Diabetes Complications. He is a trained endocrinologist with an appointment at the co-located Alfred Hospital. Dr Cooper studied medicine at the University of Melbourne and then completed his physicians training at the Austin Hospital as well as his PhD under Dr George Jerums and Professor Austin Doyle in the University of Melbourne, Department of Medicine, Austin Hospital. Dr Cooper has successfully competed for a large number of peer reviewed grants over the last 15 years from a range of organizations including not only JDRF but also the National Health and Medical Research Council of Australia, National Institutes of Health, National Heart Foundation of Australia, Diabetes Australia and Kidney Health Australia. In 1999, Dr Cooper was awarded the Eric Susman prize from the Royal Australasian College of Physicians for his research in the field of renal and vascular complications of diabetes. In 2005, he was awarded the Australian Diabetes Society (ADS) Kellion Award for outstanding contribution to diabetes research in Australia. In 1999, he was awarded a Centre Grant from JDRF which was subsequently renewed in 2003. He is a previous recipient of a scholars award from the JDRF. This work was further supported by a 5 year Australia Fellowship awarded by NHMRC in 2009. Dr Cooper is currently Co-Chair of the JDRF Medical Science Review Committee (Complications Panel). He is regularly invited to international meetings and has over 500 peer reviewed publications. Dr Cooper was the 2016 recipient of the Claude Bernard Award from the European Association for the Study of Diabetes and in 2017 the Edwin Bierman Award from the American Diabetes Association. He received an Order of Australia (Officer) in 2017.Monash University, Australia
Masahiro Eriguchi (Kyushu University, Japan)
Akira Ishii (Kyoto University, Japan)
Topic: Clinical and basic research in diabetic kidney disease
Professor Marcello Tonelli is Senior Associate Dean (Clinical Research) at the Cumming School of Medicine and Associate Vice President (Health Research) at the University of Calgary. He is a nephrologist and Professor at the University of Calgary. Prof. Tonelli is the past President of the Canadian Society of Nephrology, a former Councillor of the International Society of Nephrology, and the chair of the International Society of Nephrology Research Committee. Prof. Tonelli’s research focuses on improving the care of people with chronic kidney disease and other noncommunicable diseases. He completed a volunteership at the World Health Organization in 2013-2014, focusing on treatment of noncommunicable diseases following natural disasters and civil conflict. Prof. Tonelli was elected a fellow of the Canadian Academy of Health Sciences in 2012 and named a “Highly Cited” researcher in 2015, 2016 and 2017 by Thomson-Reuters, corresponding to a rank in the top 1% by citations of all researchers worldwide. He has completed numerous important clinical studies and published 440 papers in well-known journals including NEJM, Lancet, and JAMA. Since 2005, Prof. Tonelli has been the co-leader of a joint initiative with the Hospital Civil de Guadalajara, aimed at prevention of kidney failure in poor communities of Jalisco, Mexico.The University of Calgary, Canada
Nannaphat Atsawaphidsawat (Khon Kaen University, Thailand)
Takehiko Wada (Tokai University, Japan)
Topic: Clinical research on CKD/ESRD
Prof. Sydney Tang graduated from the University of Hong Kong and has obtained MD and PhD degrees at the University of Hong Kong. He has undergone training in basic science research in nephrology at Guy’s Hospital, King’s College London, and Seattle Children’s Hospital, University of Washington. He is currently Chair Professor of Renal Medicine and Yu Endowed Professor in Nephrology at The University of Hong Kong. His research interests range from basic to clinical sciences including the role of renal tubular cells in diabetic and proteinuric nephropathies, and the treatment of IgA nephropathy. He has published over 200 journal articles and 25 textbook chapters, edited one book, and is on the Editorial Boards of a number of nephrology journals including Kl, CJASN, NDT, American Journal of Nephrology, Nephrology, and Journal of Nephrology. He serves the Hong Kong College of Physicians as Chairman for Basic Training, and the Royal College of Physicians of Edinburgh as International Advisor. He is currently Chairman of the Hong Kong Society of Nephrology, Executive member of the Asian Pacific Society of Nephrology, and the North and East Asia Regional Board of the International Society of Nephrology. He is also on the Meetings Committee of the International Society of Nephrology. He has been invited to deliver lectures at many national and international meetings including the American Society of Nephrology Kidney Week and the World Congress of Nephrology. He is also a Subtheme Co-chair of the Scientific Committee of the Asian Pacific Congress of Nephrology to be held in Beijing in next month.The University of Hong Kong, Hong Kong
Kieta P. Mori (Kyoto University, Japan)
Naohiro Nomura (Tokyo Medical and Dental University, Japan)
Topic: The recent tribulations in clinical trial and basic research on diabetic kidney disease
Professor Shankland is head of Division of Nephrology at the University of Washington and a professor of medicine. He trained in South Africa and Canada before coming to the US. His research and clinical interests focus on glomerular diseases of the kidney, especially from the biological standpoint of glomerular parietal epithelial cell (PEC) and podocyte. His laboratory published top journals of kidney disease including KI, AJP and JASN. Recently, he published several articles on podocyte replacement in adults and showed the potential of PECs and cells of renin lineage as adult podocyte progenitor. These results indicate the podocyte compartment is more dynamic than previously thought and provide a novel therapeutic strategy for glomerular kidney diseases. He has authored more than 180 peer-reviewed publications. We welcome young participants hoping to discuss Prof. Shankland.University of Washington Medical Center, USA
Yuki Sato (Kyoto University, Japan)
Kazuhiro Takahashi (Teikyo University, Japan)
Topic: Basic research on glomeruli in disease and health
Saturday February 24, 2018, 8.00-9.00 a.m.
Xueqing Yu graduated from Sun Yat-sen University of Medical Sciences in 1984 and received his PhD in 1996 from Department of Nephrology, Sun Yat-sen University and then spent a year at Monash Medical Centre in Australia for post-doc. Now Professor of Medicine and Director of Sun Yat-sen University’s Institute of Nephrology, he’s also the Vice Chancellor of Guangdong Medical University and President of the Chinese Society of Nephrology. He also serves as the Executive member of Asian Pacific Society of Nephrology and member of East Asian of COMGAN of ISN. Yu’s research interests range from the basic to clinical and translational research. Yu and colleagues have been studying the genetic underpinnings of IgA nephropathy in Han Chinese, and among other things, comparing them with Caucasian patients. Epidemiology looms large in Yu’s portfolio as well. His group has been investigating the geographical variations of CKD prevalence; lifestyle (urban and rural), particular foodstuff, and even altitude seem to play a part. Besides his major epidemiological projects, Yu initiated a clutch of cohort studies, following up CKD and ESRD patients to figure out the risk factors that are important in influencing mortality in Chinese populations. Yu has undertaken 44 research grants, and published 443 papers in peer reviewed journals, including Nature Genetic, Nature Communication, Science Translational Medicine, Cell Metabolism, JASN, KI, etc.The First Affiliated Hospital of Sun Yat-sen University, China
Yutaka Harita (The University of Tokyo, Japan)
Noboru Fukuda (Nihon University, Japan)
Topic: Genetic and clinical associated study for kidney disease
Professor Vivekanand Jha is the Executive Director at The George Institute for Global Health, India and a Professor of Nephrology at University of Oxford. Recently, he has been elected the President-Elect of the International Society of Nephrology. He is a physician with specialization in nephrology and also a scientist in clinical and basic research of various kidney diseases and kidney transplantation. He is recognized as a global expert on kidney disease, and focuses on emerging public health threats globally and in India. He has over 220 publications in peer-reviewed journals and 30 chapters in major textbooks. He currently leads research projects operating in more than 20 countries. He has helped development of international guidelines for the management of patients with glomerulonephritis and kidney transplant recipients. We welcome young participants to discuss and exchange your experiences with him in a friendly atmosphere.George Institute for Global Health, India
Tadashi Toyama (Kanazawa University, Japan)
Megumi Oshima (Kanazawa University, Japan)
Topic: All aspects of nephrology, global health
Dr. Ravi Thadhani is currently Vice Dean of Research and Education at Cedars Sinai Medical Center in Los Angeles, California. He is also a Professor of Medicine at Harvard Medical School and, until November 2017, was Chief of the Division of Nephrology at Massachusetts General Hospital and Executive Director of the Clinical Trials Office at Partners Health Care. Dr. Thadhani is a clinical and translational investigator and, over the past 16 years, his research laboratory has focused on developing diagnostics and therapeutics related to preeclampsia and factors affecting the survival of patients receiving hemodialysis. Dr. Thadhani and his collaborators have developed novel diagnostic tests for preeclampsia, and are now arduously working on therapies to safely prolong pregnancy in women with very severe preterm preeclampsia. He has also been involved in several studies on the effect of vitamin D in hemodialysis patients and published numerous papers. Dr. Thadhani has served as a reviewer for and has published in several journals including the New England Journal of Medicine, the Lancet, the Journal of the American Society of Nephrology, Kidney International, and the Journal of Clinical Endocrinology and Metabolism. Dr. Thadhani has been the recipient of numerous honors and awards including the 2008 American Society of Clinical Investigation, Inducted Member; the 2014 Alumni Award of Merit from the Harvard School of Public Health Alumni Association; the 2015 American Association of Physicians, Inducted Member; and, in 2017, the Harold Amos Faculty Diversity Award from the Harvard Medical School.Massachusetts General Hospital, USA
Miho Tagawa (Nara Medical University, Japan)
Nobuyuki Takahashi (Tohoku University, Japan)
Topic: Angiogenic factors in CKD and preeclampsia: Is there a role for Intervention?
Prof. Philip Kam-Tao Li is the Chief of Nephrology and Consultant Physician of the Department of Medicine and Therapeutics at the Prince of Wales Hospital (PWH), Hong Kong. He is also the Honorary Professor of Medicine and the Director of the Carol and Richard Yu Peritoneal Dialysis Research Centre at the Chinese University of Hong Kong. Prof Li was the President of the Organizing Committees for the 11th Congress of ISPD 2006 in Hong Kong and of the World Congress of Nephrology 2013 respectively. He has published over 470 original and review articles in peer-reviewed journals. His research interests in PD include Residual Renal Function, Cardiovascular Disease and Peritonitis. Professor Li is also involved in the creation of ISPD guidelines and is also a member of ISPD catheter-related infection recommendations: 2017 update. Professor Li has extensive experience and knowledge on peritoneal dialysis. In this session, it will be a valuable opportunity to discuss directly with the world leading professor such as peritoneal dialysis, its complications and daily questions. We are waiting for your active participation.The Chinese University of Hong Kong, Hong Kong
Saori Nishio (Hokkaido University, Japan)
Maki Shinzawa (Osaka University, Japan)
Topic: peritoneal dialysis: Up to date
Professor WANG is a Clinician Scientist working at the Queen Mary Hospital, University of Hong Kong, Hong Kong. She is the recipient of the National Kidney Foundation Joel D. Kopple Award in 2018 and has received the John Maher Award of the ISPD in 2006, Travelling Lecturer Award of Asian and Pacific Federation of Clinical Biochemistry in 2012. She is currently President-Elect of the International Society of Renal Nutrition and Metabolism (ISRNM), Executive Committee Member of KDIGO (Jan 2015 - Dec 2017), ISN North and East Asia Regional Board member, Committee Member of the ISN-Advancing Clinical Trial Core Group, Council member of the ISPD, Executive Committee member of the SONG Initiative and a workgroup member of the SONG-PD and SONG-HD CVD. She is a current workgroup member of KDOQI Nutrition Guidelines in CKD (to be published in 2018) and the ISPD PD Adequacy Guideline update 2017. She has previously chaired the ISPD Adult Cardiovascular and Metabolic Guidelines (2012 – 2015) and is a Subcommittee Chair of the ISPD PDOPPS. She was also a Core workgroup member of the first KDIGO – CKD-MBD guidelines (2007 – 2009). She is a member of the Scientific Program Committee of WCN 2019 in Melbourne and co-Chairs the Renal Nutrition, Nurses and Allied Health Symposium at the WCN 2019. She also co-Chairs the upcoming ISN Frontiers Meeting 2019 in Gothenburg. She currently serves on the editorial board of several nephrology journals: JASN, CJASN, NDT (Editor of Cardiovascular Section), BMC Nephrology (Associate Editor), Am J Nephrol, Nephron Clin Pract (Associate Editor), Nephrology (Subject Editor), J Ren Nutr, J Diabetes, Blood Purification, Biomedicine Hub, etc. She was previously an Associate Editor of AJKD and an International Editor of CJASN. She has published over 140 scientific papers in indexed journals and has given over 100 invited lectures around the world. She is an opinion leader in clinical research relating to CKD and dialysis complications, especially in the areas of cardiovascular disease, heart failure, vascular calcification, CKD-MBD, diet and nutrition as well as residual kidney function in PD. She is the Principal Investigator of OPERA Trial, CASCADE study, and the PROOF Trial.The University of Hong Kong, Hong Kong
Keiichi Sumida (Toranomon Hospital, Japan)
Kan Katayama (Mie University, Japan)
Topic: Clinical research in CKD and dialysis-related complications
Dr. Orson Moe is a nephrologist who is Professor of Internal Medicine and Physiology at the University of Texas Southwestern Medical Center where he practices medicine, teaches, conducts several research programs in both basic and clinical research. His administrative duties include Director of the Center of Mineral Metabolism and Clinical Research and Chief of the Division of Nephrology. His research is mainly focused on preclinical pathophysiology in electrolytes disorders, mineral metabolism, cardiovascular complications in CKD, and AKI-CKD transition.University of Texas Southwestern Medical Center, USA
Takaaki Wada (Kanazawa University, Japan)
Eisei Sohara (Tokyo Medical and Dental University, Japan)
Topic: Electrolyte and mineral metabolism
We look forward to receiving your application!
ISN Frontiers Meetings 2018
Meet the Professor committee